Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) — Financial Flexibility Index
Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Financial Flexibility Index of 0.85x as of September 2025. Free cash flow of CN¥609.18 Million (operating CF CN¥504.02 Million minus capex CN¥105.16 Million) represents 1% of total liabilities (CN¥719.98 Million). Check Chengdu Kanghong Pharmaceuticals Group C (002773) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chengdu Kanghong Pharmaceuticals Group Co Ltd Financial Flexibility Index (2009–2025)
Historical Financial Flexibility Index trend for Chengdu Kanghong Pharmaceuticals Group Co Ltd across 17 annual periods. See 002773 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
Year-by-year free cash flow to debt coverage for Chengdu Kanghong Pharmaceuticals Group Co Ltd. For the full company profile including market capitalisation, see Chengdu Kanghong Pharmaceuticals Group C market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.74x | CN¥1.77 Billion | CN¥1.50 Billion | CN¥645.22 Million | ▲ +21.1% |
| 2024 | 2.26x | CN¥1.57 Billion | CN¥1.41 Billion | CN¥695.07 Million | ▲ +19.5% |
| 2023 | 1.89x | CN¥1.36 Billion | CN¥1.22 Billion | CN¥717.76 Million | ▲ +20.2% |
| 2022 | 1.57x | CN¥1.28 Billion | CN¥925.15 Million | CN¥813.85 Million | ▲ +25.9% |
| 2021 | 1.25x | CN¥1.06 Billion | CN¥494.11 Million | CN¥851.08 Million | ▲ +75.0% |
| 2020 | 0.71x | CN¥890.38 Million | CN¥273.32 Million | CN¥1.25 Billion | ▼ -51.5% |
| 2019 | 1.47x | CN¥1.78 Billion | CN¥812.15 Million | CN¥1.21 Billion | ▲ +102.0% |
| 2018 | 0.73x | CN¥809.33 Million | CN¥350.88 Million | CN¥1.11 Billion | ▼ -29.6% |
| 2017 | 1.04x | CN¥1.08 Billion | CN¥766.86 Million | CN¥1.04 Billion | ▼ -13.1% |
| 2016 | 1.19x | CN¥1.02 Billion | CN¥846.35 Million | CN¥853.27 Million | ▼ -25.0% |
| 2015 | 1.59x | CN¥597.80 Million | CN¥481.97 Million | CN¥376.19 Million | ▲ +37.0% |
| 2014 | 1.16x | CN¥381.65 Million | CN¥291.38 Million | CN¥329.11 Million | ▼ -13.6% |
| 2013 | 1.34x | CN¥410.47 Million | CN¥333.31 Million | CN¥305.69 Million | ▲ +22.5% |
| 2012 | 1.10x | CN¥411.35 Million | CN¥281.84 Million | CN¥375.39 Million | ▲ +20.8% |
| 2011 | 0.91x | CN¥326.11 Million | CN¥168.86 Million | CN¥359.58 Million | ▲ +23.7% |
| 2010 | 0.73x | CN¥268.56 Million | CN¥136.79 Million | CN¥366.21 Million | ▼ -22.0% |
| 2009 | 0.94x | CN¥266.69 Million | CN¥108.42 Million | CN¥283.73 Million | — |